|
|
||||||||

* Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden;
# Department of Immunology, ImClone Systems Inc., New York, USA; and
Molecular/Cancer Biology Laboratory, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland
1 Correspondence: Department of Genetics and Pathology, Vascular Biology Unit, Rudbeck Laboratory, Uppsala University, S-751 85 Uppsala, Sweden. E-mail: Stefan.Wennstrom{at}genpat.uu.se
Reduced tissue oxygen tension (hypoxia) is appreciated as an efficient stimulus for neovascularization. The effect of hypoxia on the very first stages of vascular development is, however, less well characterized. Here we show that hypoxic conditions (1% O2) potently stimulated formation of an extensive vascular network during a discrete stage of mouse embryonal stem cell differentiation. The morphological changes correlated with an expanding pool of endothelial cells and with activation of the vascular endothelial growth factor-d (Vegf-d) and Vegf receptor-3 genes. VEGF receptor-3 expression was confined to vascular endothelial cells and analysis of the lymphatic marker Prox-1 revealed no expansion of lymphatic endothelial cells. Administration of neutralizing antibodies against either VEGF receptor-3 or VEGF receptor-2 impaired vascular network formation, whereas neutralizing antibodies against VEGF receptor-1 potentiated development of immature vascular structures. In addition, sequestering of VEGF receptor-3 ligands reduced vascularization in a manner similar to neutralization of VEGF receptor-3. We conclude that hypoxia-driven vascular development requires the activity of VEGF receptor-3.Nilsson, I., Rolny, C., Wu, Y., Pytowski, B., Hicklin, D., Alitalo, K., Claesson-Welsh, L., Wennström, S. Vascular endothelial growth factor receptor-3 in hypoxia-induced vascular development.
Key Words: embryoid body endothelial cell hypoxia VEGFR-3
This article has been cited by other articles:
![]() |
K. A. Radek, E. J. Kovacs, R. L. Gallo, and L. A. DiPietro Acute ethanol exposure disrupts VEGF receptor cell signaling in endothelial cells Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H174 - H184. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Brideau, M. J. Makinen, H. Elamaa, H. Tu, G. Nilsson, K. Alitalo, T. Pihlajaniemi, and R. Heljasvaara Endostatin Overexpression Inhibits Lymphangiogenesis and Lymph Node Metastasis in Mice Cancer Res., December 15, 2007; 67(24): 11528 - 11535. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. U. Magnusson, C. Looman, A. Ahgren, Y. Wu, L. Claesson-Welsh, and R. L. Heuchel Platelet-Derived Growth Factor Receptor-{beta} Constitutive Activity Promotes Angiogenesis In Vivo and In Vitro Arterioscler. Thromb. Vasc. Biol., October 1, 2007; 27(10): 2142 - 2149. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ohnishi, T. Yasuda, S. Kitamura, and N. Nagaya Effect of Hypoxia on Gene Expression of Bone Marrow-Derived Mesenchymal Stem Cells and Mononuclear Cells Stem Cells, May 1, 2007; 25(5): 1166 - 1177. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Laakkonen, M. Waltari, T. Holopainen, T. Takahashi, B. Pytowski, P. Steiner, D. Hicklin, K. Persaud, J. R. Tonra, L. Witte, et al. Vascular Endothelial Growth Factor Receptor 3 Is Involved in Tumor Angiogenesis and Growth Cancer Res., January 15, 2007; 67(2): 593 - 599. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kono, H. Kubo, C. Shimazu, Y. Ueda, M. Takahashi, K. Yanagi, N. Fujita, T. Tsuruo, H. Wada, and J. K. Yamashita Differentiation of Lymphatic Endothelial Cells From Embryonic Stem Cells on OP9 Stromal Cells Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 2070 - 2076. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kreuger, I. Nilsson, D. Kerjaschki, T. Petrova, K. Alitalo, and L. Claesson-Welsh Early Lymph Vessel Development From Embryonic Stem Cells Arterioscler. Thromb. Vasc. Biol., May 1, 2006; 26(5): 1073 - 1078. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Liersch, F. Nay, L. Lu, and M. Detmar Induction of lymphatic endothelial cell differentiation in embryoid bodies Blood, February 1, 2006; 107(3): 1214 - 1216. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |